Spirea Limited, a Cambridge-based startup working to develop a new generation of antibody-drug conjugate (ADC) treatments
Spirea Limited has raised €2.8M across 1 funding round, most recently a round in Jun 2022. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-14 | Other | €2.8M |
| — |
| View deal → |
